Micromeritics Scientist Elected to General Chapters-Physical Analysis Expert Committee - 7/20/2015
Senior Pharmaceutical Scientist Myke Scoggins, Ph.D
. was recently elected to serve on the 2015 – 2020 Convention Cycle for the United State Pharmacopeial Convention (USP). The role of this Expert Committee is to develop new and revise existing general chapters related to physical analysis (e.g., particles, powders, rheology).
USP Expert Committees are responsible for developing and revising USP standards that comprise its compendia: the USP and the NF, USP Compounding Compendium, Herbal Medicines Compendium, Dietary Supplements Compendium, and Food Chemicals Codex. They are each focused on a different area of standards for medicines (including chemical medicines, biologic medicines, excipients, and compounded preparations), dietary supplements, and food ingredients. Expert Committees publish proposed standards for public comment, then review public comments related to the draft standards. The standards are adjusted based on Expert Committee consideration of the public comments, and then are adopted by those USP expert volunteers by a majority vote.
Dr. Myke Scoggins earned his BS in Microbiology from the University of Georgia and a Ph.D. in Pharmaceutical Sciences from Mercer University. He has over 20 years of experience in the pharmaceutical industry including analytical chemistry, preformulation, formulation, process development and validation, scale-up, tech transfer, and manufacturing support. Currently, Dr. Scoggins holds the position of Senior Pharmaceutical Scientist working both internally and with external partners on applications and support for Micromeritics’ instrument lineup as they relate to the pharmaceutical industry. Prior to this, he served as Pharmaceutical Scientist and Laboratory Manager for Micromeritics Analytical Services and Micromeritics Pharmaceutical Services – the contract services laboratories housed within Micromeritics. Before joining Micromeritics, Dr. Scoggins worked with a medical device company managing microbial and chemical testing as well as sterilization validations. He has worked at generic pharmaceutical companies, larger international companies, and as Research Scientist at the Georgia Institute of Technology developing dissolving microneedle technology for influenza vaccine delivery. He has given numerous lectures on topics in the pharmaceutical sciences to PhD students and at University-sponsored continuing education conferences, helped develop graduate courses in pharmaceutical sciences at local universities, and presented research findings at national meetings. Dr. Scoggins is currently a member of the American Association of Pharmaceutical Scientists (AAPS).